REFERENCES
- Glantz M J, Cole D F, Glantz L K, et al, Cerebrospinal fluid cytology in patients with cancer. Minimizing false-negative results. Cancer. 1998; 82: 733–739
- Kersten M J, Evers L M, Dellemijn P LI, et al, Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood. 1996; 87: 1985–1989. [PUBMED], [INFOTRIEVE], [CSA]
- van den, Bent M J, Lamers C H, van't, Veer M B, et al, Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. Ann Hematol. 2002; 81: 187–191. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hanley J A, Mc, Neil B J. The meaning and the use of the area under the receiver operating characteristics (ROC) curve. Radiology. 1982; 143: 29–36. [PUBMED], [INFOTRIEVE]
- Bigner S H, Johnston W W. The cytopathology of cerebrospinal fluid. Part I, Non-neoplastic conditions, lymphoma and leukemia. Acta Cytol. 1981; 25: 345–53. [PUBMED], [INFOTRIEVE]
- Marton K I, Gean A D. The spinal tap: a new look at an old test. Annals of Internal Medicine. 1986; 104: 840–848. [PUBMED], [INFOTRIEVE]
- Hovestadt A, Henzen-Logmans S C, Vecht Ch. J. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cancer. 1990; 62: 653–654. [PUBMED], [INFOTRIEVE]
- Weller M, Stevens A, Sommer N, et al, Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia. Acta Neurol Scand. 1992; 86: 129–133. [PUBMED], [INFOTRIEVE]
- Hansen P B, Kjeldsen L, Dalhoff K, Olesen B. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS involvement. Acta Neurol Scand. 1992; 85: 224–227. [PUBMED], [INFOTRIEVE]
- Maylight G M, Stuckey S E, Cabanillas F F, et al, Diagnosis of leukemia or lymphoma in the central nervous system by beta-2-microglobulin determination. N Engl J Med. 1980; 303: 718–22. [CSA]
- Jeffery G M, Frampton C M, Legge H M, Hart D N. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy. Pathology. 1990; 22: 20–23. [PUBMED], [INFOTRIEVE]
- Pudek M R, Chan K W, Rogers P C, Teasdale J M. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma. Clin Biochem. 1985; 18: 180–183. [PUBMED], [INFOTRIEVE]
- Hintzen R Q, de, Jong R, Hack C E, et al, A soluble form of the human T-cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol. 1991; 147: 29–35. [PUBMED], [INFOTRIEVE]
- Hintzen R Q, van, Lier R A, Kuijpers K C, et al, Elevated levels of a soluble form of the T cell activation antigen in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 1991; 35: 211–217. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chamuleau M ED, ten, Berge I J, Schellekens P TA, et al, Serum levels of soluble CD27 in renal transplant recipients. Transplantation. 1992; 54: 932–936. [PUBMED], [INFOTRIEVE]
- Font J, Pallares L, Martorell J, et al, Clin Immunol Immunopathol. 1996; 81: 239–243. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van, Oers M HJ, Pals S T, Evers L M, et al, Expression and release of CD27 in human B-cell malignancies. Blood. 1993; 82: 3430–3436. [PUBMED], [INFOTRIEVE], [CSA]